Notice of NINDS Specific Interest in AD/ADRD for PAS-22-196 "Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)"
Notice NOT-NS-23-049 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 1, 2022 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for the National Institute on Aging (NIA) Alzheimer's Disease (AD) and Alzheimer's Disease-Related Dementias (ADRD) Real-World Data (RWD) Platform Initiative (U54 Clinical Trial Required)
Notice NOT-AG-22-044 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 19, 2022 Category: Research Source Type: funding
Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD) (U24 Clinical Trial Optional)
Funding Opportunity RFA-AT-23-006 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support a collection of research networks that promote multidisciplinary mechanistic studies of music-based interventions (MBIs) for pain or Alzheimers disease and Alzheimers disease related dementias (AD/ADRD). These networks are expected to develop compelling research frameworks that will guide future clinical research on MBIs in these health conditions effectively, adopt consistent terminology and taxonomy, support interdisciplinary collaborations, initiate pilot projects testing novel mechanistic hypotheses, ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 17, 2022 Category: Research Source Type: funding
Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (R61/R33 Clinical Trial Required)
Funding Opportunity RFA-AG-23-034 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to address psychological and interpersonal mechanisms driving adherence to behaviors or lifestyle changes relevant to prevention of cognitive decline, Mild Cognitive Impairment (MCI), and Alzheimer's disease (AD) and AD-related dementias (ADRD). Mechanisms of adherence may be studied in new, early- to late-stage (including Stage I-IV) behavior change trials. Applications will seek to identify malleable, mechanistic, psychological, or interpersonal targets that, if modified, will...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 3, 2022 Category: Research Source Type: funding
Notice of Special Interest: Development of Radiotracers for Diagnosis and Clinical Studies in Alzheimer's Disease (AD) and AD-Related Dementias (ADRD)
Notice NOT-AG-22-032 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 28, 2022 Category: Research Source Type: funding
Request for Information (RFI) for the National Institute on Aging (NIA) Alzheimers Disease (AD) and AD-Related Dementias (ADRD) Real-World Data (RWD) Platform
Notice NOT-AG-22-039 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 28, 2022 Category: Research Source Type: funding
Notice of Change to Key Dates to PAS-22-197, "Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)"
Notice NOT-AG-22-038 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 20, 2022 Category: Research Source Type: funding
Notice of Change to Key Dates to PAS-22-196, "Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)"
Notice NOT-AG-22-037 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 15, 2022 Category: Research Source Type: funding
Understanding the Supply of Professional Dementia Care Providers and Their Decisions (U54 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-23-018 from the NIH Guide for Grants and Contracts. This RFA supports a national survey of professional dementia care providers and link consented survey respondents (providers and institutional representative) that consent to administrative data (e.g., electronic health records, claims, payroll, other institutional and state level data). This new resource anticipates the integration from administrative sources with the provider survey to expand research on the dementia care workforce, supply of skilled labor, and provide deeper insight into how professional care providers and institutions pro...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 1, 2022 Category: Research Source Type: funding
Notice of Correction to the Application Types Allowed Information for PAS-22-197, Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
Notice NOT-AG-22-029 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 26, 2022 Category: Research Source Type: funding
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Independent Clinical Trial Not Allowed)
Funding Opportunity PAR-22-226 from the NIH Guide for Grants and Contracts. The purpose of the Research and Entrepreneurial Development Immersion (REDI): NIA Entrepreneurship Enhancement Award (R25) is to promote the development of entrepreneurial training programs that are designed to broaden the skillset of graduate students and postdocs, as well as early career master's, Ph.D., and Dr.P.H. scientists, in fields relevant to the mission of NIA, including aging and Alzheimer's disease (AD) research. The goal of this program is to prepare trainees for a wide range of career paths, including those that are outside the nor...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 24, 2022 Category: Research Source Type: funding
Optimization of Genome Editing Therapeutics for Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) (U01 - Clinical Trials Not Allowed)
Funding Opportunity RFA-NS-23-017 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports the optimization of promising genome editing-based therapeutic leads for Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD), towards IND-enabling studies. Specifically, it supports the characterization and optimization of therapeutic lead(s) that show promise as potential genome editing therapeutics, as evidenced by convincing proof-of-concept studies in appropriate models. At the end of the funding period, successful projects will have optimized a genome editing therap...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 24, 2022 Category: Research Source Type: funding
Training Award to Promote Cross-Training in the Fields of Traumatic Brain Injury (TBI) as a Risk Factor for Alzheimers Disease/Alzheimers Disease Related Dementias (AD/ADRD) (K18 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-22-061 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement invites applications from established investigators who strive to expand their research trajectories through the acquisition of new knowledge and skills in the areas of traumatic brain injury (TBI) as a risk factor for Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD). This funding opportunity encourages applications for short-term (2 yrs.) mentored career enhancement awards to further understand TBI as a risk factor for AD/ADRD. Two categories of candidates are targeted: (a) establi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 16, 2022 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Administrative Supplements for NIA-VA Mentored Physician and Clinical Psychologist Scientist Award in Alzheimers Disease (AD) and AD-Related Dementias (ADRD)
Notice NOT-AG-22-020 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 10, 2022 Category: Research Source Type: funding
Connecting Machine Readable Digital Human AD/ADRD Neuropathological Library Platforms for Advanced Analytics (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-22-062 from the NIH Guide for Grants and Contracts. The purpose of this NINDS-led Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD) initiative is to 1) develop tools, standards, and an Open-source software platform that enables a federated (multiple data repository sites with a single access portal) approach for data sharing and analysis of human digital neuropathological slides and 2) perform software testing to validate and verify that the software and tools developed can be used to perform multisite neuropathological analyses using a federated approach. The federated a...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 9, 2022 Category: Research Source Type: funding
